An industry piece on the production challenges facing ADCs, bispecifics, peptides and other newer drug types, and how makers are solving them.
Recap by typeshit. Full story at BioPharma Dive.
The EMA's CHMP amended its type 2 diabetes indication, and Italian diabetologists say Italy could be the first European country to offer the once-weekly combo.
26:19
A personal update from TakingWeightOff on life after stopping tirzepatide, three weeks in, and what caught them off guard.
Nyah Phengsitthy reports Lilly is staking out a new battlefront around an unapproved obesity treatment. The full story has the details.
A history of drug advertising, from opium-laced tonics and Radithor to the 1938 law after Elixir Sulfanilamide killed over 100 people. Semaglutide is mostly a hook.
Mariem Dekhili's weekly overview covers GLP-1 eye warnings alongside the Pope's France visit and Russia in the Sahel.
A practical rundown of insurance coverage for Wegovy when it is prescribed for weight loss, aimed at people sorting out costs.
Loading…